We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Merck to Get Remicade Distribution Rights in Merger
Merck to Get Remicade Distribution Rights in Merger
March 13, 2009
Merck and Schering-Plough’s $41.1 billion merger will create a company with a pipeline of 18 drugs in Phase III clinical trials and combined treatments in areas such as cardiology, oncology, respiratory disease and immunology, including distribution rights to Remicade.